Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

23 June 2020: Clinical Research

The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis

Mei Tian 1BE* , Xiuchun Yang 1CD* , Yanfang Li 1BF , Sen Guo 2ABCDEFG*

DOI: 10.12659/MSM.923359

Med Sci Monit 2020; 26:e923359

Figure 1 The expression of dynamin 1, 2, and 3 in tissue sections of hepatocellular carcinoma (HCC) and adjacent normal liver tissues using immunohistochemistry and quantitative real-time polymerase chain reaction (qRT-PCR). (A–C) The expression of dynamin 1, 2, and 3 detected with immunohistochemistry. Representative photomicrographs of the HCC tissue show positive immunostaining for dynamin. (D) The mRNA level of dynamin 1, 2, and 3, were detected by qRT-PCR in 14 paired tissue samples of HCC and normal adjacent liver tissue.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750